Eisenberg P R, Jaffe A S
Cardiol Clin. 1987 Feb;5(1):129-41.
The decision to administer thrombolytic agents to patients with acute myocardial infarction requires consideration of both the potential risks and benefits of treatment. In patients treated very early (1 to 2 hours) after the onset of infarction, benefit has been established. In those presenting later, factors such as age, location of infarction, the interval from the onset of symptoms to treatment, and any risks of therapy need to be weighed. This article will review the selection of patients for treatment, the state of the art for its implementation, and for the use of adjunctive therapies.
决定对急性心肌梗死患者使用溶栓药物需要考虑治疗的潜在风险和益处。在梗死发作后很早（1至2小时）接受治疗的患者中，治疗益处已得到证实。对于就诊较晚的患者，需要权衡年龄、梗死部位、症状发作至治疗的间隔时间以及任何治疗风险等因素。本文将回顾治疗患者的选择、实施的最新技术以及辅助治疗的使用情况。
